Fatal Burkholderia gladioli infection misidentified as Empedobacter brevis in a lung transplant recipient with cystic fibrosis

Transpl Infect Dis. 2012 Aug;14(4):E13-8. doi: 10.1111/j.1399-3062.2012.00726.x. Epub 2012 Mar 19.

Abstract

Data describing the risk of lung transplantation (LT), clinical features, and outcomes of patients with cystic fibrosis (CF) infected with Burkholderia gladioli are limited. Herein, we report a case of disseminated B. gladioli infection characterized by bacteremia, necrotizing pneumonia, lung abscess, and empyema in a lung transplant recipient with CF, highlight the importance of accurate microbiological identification, and review published outcomes of LT in CF patients infected with B. gladioli, which include cases of pneumonia, tracheobronchitis, bacteremia, and abscesses, and demonstrate an all-cause 1-year mortality of approximately 23%, often after combined medical and surgical treatment.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Burkholderia Infections / diagnosis*
  • Burkholderia Infections / microbiology
  • Burkholderia Infections / physiopathology
  • Burkholderia gladioli / classification*
  • Burkholderia gladioli / isolation & purification
  • Cystic Fibrosis / complications
  • Cystic Fibrosis / microbiology*
  • Diagnostic Errors*
  • Fatal Outcome
  • Flavobacteriaceae / classification*
  • Flavobacteriaceae / isolation & purification
  • Flavobacteriaceae Infections / diagnosis
  • Flavobacteriaceae Infections / microbiology
  • Humans
  • Lung Transplantation / adverse effects*
  • Male